Interface Biologies Inc. – Trademark Portfolio

Entity Type: 03

Interface Biologies Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include EPIDEL. The owner is based in Toronto, Ontario.

MaRS Centre, South Tower

101 College Street, Suite 300

Toronto, Ontario M5G1L7 , CA

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EPIDEL
EPIDEL
Registered 2009
KINESYX
KINESYX
Abandoned 2002

Trademark Classifications

Interface Biologies Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Interface Biologies Inc. have?

Interface Biologies Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Interface Biologies Inc. file in?

Interface Biologies Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Interface Biologies Inc.'s most well-known trademarks?

Interface Biologies Inc.'s registered trademark portfolio includes well-known marks such as EPIDEL. These are among 1 currently registered trademark in the portfolio.

What is Interface Biologies Inc.'s trademark registration success rate?

Interface Biologies Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.